>
Switch to:

Cellectar Biosciences E10

: $-151.94 (As of Sep. 2021)
View and export this data going back to 2005. Start your Free Trial

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cellectar Biosciences's adjusted earnings per share data for the three months ended in Sep. 2021 was $-0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-151.94 for the trailing ten years ended in Sep. 2021.

As of today (2021-12-04), Cellectar Biosciences's current stock price is $0.611. Cellectar Biosciences's E10 for the quarter that ended in Sep. 2021 was $-151.94. Cellectar Biosciences's Shiller PE Ratio of today is .


Cellectar Biosciences E10 Historical Data

The historical data trend for Cellectar Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellectar Biosciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
E10
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60,826.20 -34,658.90 -15,016.80 1,627.59 -202.05

Cellectar Biosciences Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
E10 Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -211.39 -202.05 -186.51 -167.25 -151.94

Competitive Comparison

For the Biotechnology subindustry, Cellectar Biosciences's E10, along with its competitors' market caps and E10 data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cellectar Biosciences E10 Distribution

For the Biotechnology industry and Healthcare sector, Cellectar Biosciences's E10 distribution charts can be found below:

* The bar in red indicates where Cellectar Biosciences's E10 falls into.



Cellectar Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cellectar Biosciences's adjusted earnings per share data for the three months ended in Sep. 2021 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2021 (Change)*Current CPI (Sep. 2021)
=-0.1/115.7343*115.7343
=-0.100

Current CPI (Sep. 2021) = 115.7343.

Cellectar Biosciences Quarterly Data

per share eps CPI Adj_EPS
201112 -120.000 95.213 -145.863
201203 -120.000 96.783 -143.498
201206 -120.000 96.819 -143.444
201209 -120.000 97.633 -142.248
201212 -100.000 96.871 -119.472
201303 -140.000 98.209 -164.982
201306 -72.000 98.518 -84.582
201309 -46.000 98.790 -53.890
201312 -139.000 98.326 -163.610
201403 -103.000 99.695 -119.572
201406 -73.000 100.560 -84.016
201409 6.000 100.428 6.914
201412 -44.255 99.070 -51.699
201503 -30.400 99.621 -35.317
201506 -30.200 100.684 -34.714
201509 -24.600 100.392 -28.360
201512 15.000 99.792 17.396
201603 9.100 100.470 10.483
201606 -4.900 101.688 -5.577
201609 -4.300 101.861 -4.886
201612 -5.560 101.863 -6.317
201703 -2.400 102.862 -2.700
201706 -2.320 103.349 -2.598
201709 -2.580 104.136 -2.867
201712 -3.400 104.011 -3.783
201803 -2.070 105.290 -2.275
201806 -1.690 106.317 -1.840
201809 -1.650 106.507 -1.793
201812 -0.809 105.998 -0.883
201903 -0.760 107.251 -0.820
201906 -0.460 108.070 -0.493
201909 -0.420 108.329 -0.449
201912 -0.330 108.420 -0.352
202003 -0.420 108.902 -0.446
202006 -0.260 108.767 -0.277
202009 -0.150 109.815 -0.158
202012 -0.070 109.897 -0.074
202103 -0.130 111.754 -0.135
202106 -0.110 114.631 -0.111
202109 -0.100 115.734 -0.100

Add all the adjusted EPS together and divide 10 will get our e10.


Cellectar Biosciences  (NAS:CLRB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cellectar Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Cellectar Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellectar Biosciences Business Description

Cellectar Biosciences logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
100 Campus Drive, Florham Park, NJ, USA, 07932
Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.
Executives
Friend John E. Ii officer: VP, Chief Medical Officer 26 ORCHARD LANE COLT NECK NJ 07722
Swirsky Douglas J director C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD SUITE 455 ROCKVILLE MD 20850
Neis John director 505 S. ROSA ROAD, SUITE 201 MADISON WI 53719
Hill Stephen A director 50 AVENUE GENERAL DE GAULLE BRUXELLES C9 9999999999
Driscoll Frederick W director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: DRISCOLL FREDERICK W a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Loren Stefan director 3226 AVENIDA DE SUENO CARLSBAD CA 92009
Elefant Dov officer: Chief Financial Officer EPICEPT CORPORATION 270 SYLVAN AVENUE ENGLEWOOD CLIFFS NJ 07632
Caruso James V director, officer: President and CEO C/O CELLECTAR BIOSCIENCES, INC. 8383 GREENWAY BLVD STE 600 MIDDLETON WI 53562
Longcor Jarrod officer: Chief Business Officer C/O RIB-X PHARMACEUTICALS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Grachev Igor D officer: Chief Medical Officer 15 REID LANE MILLSTONE TWP NJ 08535
Bernhardt Charles Thomas Iii officer: Interim CFO 23 BIRCH ROAD MALVERN PA 19355
Posner Brian M officer: Chief Financial Officer 1590 REED ROAD PENNINGTON NJ 08534
Hamill John P. officer: Interim CFO 4092 NEW HOPE ROAD FURLONG PA 18925
Kolean Chad J officer: VP, Chief Financial Officer C/O CELLECTAR BIOSCIENCES, INC. 3301 AGRICULTURE DRIVE MADISON WI 53716
Hertzberg Richard other: significant owner 1329 STRATFORD COURT DEL MAR CA 92014

Cellectar Biosciences Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)